Email Print Share

News From the Field

Antibody's unusual abilities might inspire vaccine strategies


May 14, 2015

This material is available primarily for archival purposes. Telephone numbers or other contact information may be out of date; please see current contact information at media contacts.

The recent discovery of a novel antibody that works in an unusual way could inspire new vaccine strategies. The antibody appears to have properties that might keep bacteria like disease-causing E. coli from adhering to human cell surfaces and also dislodge those already attached. Among the common pathogens for which researchers are seeking more effective methods to prevent adherence to human cell surfaces are the forms of E. coli that cause urinary tract infections.Full Story

Source
University of Washington Health Sciences/UW Medicine

The U.S. National Science Foundation propels the nation forward by advancing fundamental research in all fields of science and engineering. NSF supports research and people by providing facilities, instruments and funding to support their ingenuity and sustain the U.S. as a global leader in research and innovation. With a fiscal year 2023 budget of $9.5 billion, NSF funds reach all 50 states through grants to nearly 2,000 colleges, universities and institutions. Each year, NSF receives more than 40,000 competitive proposals and makes about 11,000 new awards. Those awards include support for cooperative research with industry, Arctic and Antarctic research and operations, and U.S. participation in international scientific efforts.

mail icon Get News Updates by Email 

Connect with us online
NSF website: nsf.gov
NSF News: nsf.gov/news
For News Media: nsf.gov/news/newsroom
Statistics: nsf.gov/statistics/
Awards database: nsf.gov/awardsearch/

Follow us on social
Twitter: twitter.com/NSF
Facebook: facebook.com/US.NSF
Instagram: instagram.com/nsfgov